Automated description from the Alliance of Genome Resources
Predicted to have high-density lipoprotein particle receptor binding activity; lipase inhibitor activity; and phospholipid binding activity. Involved in cholesterol metabolic process; triglyceride catabolic process; and triglyceride mobilization. Predicted to localize to the chylomicron; spherical high-density lipoprotein particle; and triglyceride-rich plasma lipoprotein particle. Human ortholog(s) of this gene implicated in chronic kidney disease; cognitive disorder; coronary artery disease; familial hyperlipidemia (multiple); and glucose metabolism disease (multiple). Orthologous to human APOC3 (apolipoprotein C3).